(NYSE:GMED) AUDUBON, Pa., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, announced that a Delaware jury has returned a verdict in favor of Globus in its patent infringement litigation against Life Spine, Inc.
Related Questions
What potential damages or licensing revenue could result from the judgment, and how might that impact earnings forecasts?
How will the favorable verdict affect GMED's short‑term share price and trading volume?
Could this legal win set a precedent affecting other orthopedic device patents and influence the competitive landscape?